Flywheel, a cloud-scale informatics platform for biomedical research and collaboration, announced the successful integration of its platform by https://www.gene.com/about-usRoche and Genentech, a member of the Roche Group, for ingestion, classification, standardization, curation and analysis of medical imaging data.

November 23, 2021 — Flywheel, a cloud-scale informatics platform for biomedical research and collaboration, announced the successful integration of its platform by Roche and Genentech, a member of the Roche Group, for ingestion, classification, standardization, curation and analysis of medical imaging data.

The secure, scalable Flywheel platform enables aggregation and management of medical imaging and associated data to accelerate drug discovery. The data is organized and processed with automated pipelines—saving significant time and minimizing the potential for human error in the drug development process. Cost and timeline efficiencies allow researchers to focus on what matters most—bringing life-changing therapies to patients faster. Moreover, Flywheel’s unique approach has enabled multi-site collaboration and development of a customized solution for Roche and Genentech’s needs.

“Manual processes to curate data at the terabyte and petabyte levels are historically costly, time-consuming and prone to human error. With our platform in place, Roche and Genentech researchers can access high-quality images for complex analysis and machine learning, ultimately speeding the development of innovative therapies,” said Jim Olson, CEO of Flywheel. “Before using the platform, this level of collaboration and analysis was simply not possible.”

“At Roche we envision a future where data, analytics and digital technologies routinely enable more targeted, efficient research and development and more integrated, personalized care,” said James Sabry, head of Roche Pharma Partnering. “The Flywheel platform enables rapid access to highly-curated imaging data, enhancing our ability to answer key scientific questions that are critical to advancing better patient care experiences and outcomes.”

Life sciences organizations are making significant investments in digital transformations that foster AI technology in hopes of improving R&D processes and bringing drugs to the market faster. Modern infrastructures are needed to aggregate, curate, and analyze a vast assortment of rich, biomedical data to support these initiatives and enable machine learning, big data analytics, and other strategic data-driven objectives.

For more information: www.flywheel.io

Additional RSNA21 conference coverage can be found here.

Related Content

News | Electronic Medical Records (EMR)

May 20, 2022 — DrChrono Inc., an EverHealth solution and essential platform for modern medical practices, announced that ...

Time May 20, 2022
arrow
News | Contrast Media

May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...

Time May 19, 2022
arrow
Feature | Radiology Business | By Merilee Kern, MBA

Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...

Time May 18, 2022
arrow
News | Enterprise Imaging

May 16, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics ...

Time May 16, 2022
arrow
News | Lung Imaging

May 13, 2022 — Median Technologies announced that the company has received feedback from the United States Food and Drug ...

Time May 13, 2022
arrow
News | Radiology Business

May 11, 2022 — Enlitic, a leading AI healthcare company, has welcomed Dave Wilson as the vice president of marketing and ...

Time May 11, 2022
arrow
News | Teleradiology

May 6, 2022 — Jefferson Radiology has implemented advanced telemedicine software for its diagnostic ultrasound ...

Time May 06, 2022
arrow
Feature | Digital Radiography (DR) | By Melinda Taschetta-Millane

The COVID-19 pandemic turned the spotlight on diagnostic imaging by demanding a need for high-speed workflow and ...

Time May 03, 2022
arrow
Feature | Enterprise Imaging | By Jef Williams

Organizations are rapidly expanding their enterprise imaging architecture to accommodate imaging that is being generated ...

Time May 03, 2022
arrow
Feature | Radiology Business | By Christine Book

At the Radiological Society of North America’s (RSNA) 2021 annual meeting in December, James Brink, MD, FACR ...

Time May 03, 2022
arrow
Subscribe Now